Tarsus Pharmaceuticals Inc. (TARS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tarsus Pharmaceuticals In...

    NASDAQ: TARS · Real-Time Price · USD
    65.17
    6.40 (10.89%)
    At close: Oct 03, 2025, 3:59 PM
    65.27
    0.15%
    After-hours: Oct 03, 2025, 07:32 PM EDT

    Tarsus Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -115.55M -135.89M -62.09M -13.83M
    Depreciation & Amortization
    		 1.23M 877K 325K 312K
    Stock-Based Compensation
    		 27.82M 19.83M 13.46M 8.46M
    Other Working Capital
    		 -4.31M 4.3M -1.77M -2.51M
    Other Non-Cash Items
    		 -360K -2.61M 227K 5.79M
    Deferred Income Tax
    		 n/a n/a n/a 1.65M
    Change in Working Capital
    		 3.84M 306K -951K 1.37M
    Operating Cash Flow
    		 -83.03M -117.49M -49.03M 3.75M
    Capital Expenditures
    		 -1.57M -1.5M -506K -586K
    Cash Acquisitions
    		 n/a n/a 144.12M n/a
    Purchase of Investments
    		 -265.63M -28.66M -149.44M n/a
    Sales Maturities Of Investments
    		 73M 174.77M 5.32M n/a
    Other Investing Acitivies
    		 -5M -4M -144.12M n/a
    Investing Cash Flow
    		 -199.19M 140.6M -144.63M -586K
    Debt Repayment
    		 75M 10M 20M n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -18.63M 1.58M -365K 21K
    Financial Cash Flow
    		 154.66M 130.18M 93.99M 21K
    Net Cash Flow
    		 -127.57M 153.29M -99.67M 3.18M
    Free Cash Flow
    		 -84.59M -123M -49.54M 3.16M

    Add to Watchlist